The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 17 Jan 2006
doi: 10.1242/jcs.02773
Research Article
The major vault protein is responsive to and interferes with interferon-
-mediated STAT1 signals
Elisabeth Steiner,
Klaus Holzmann,
Christine Pirker,
Leonilla Elbling,
Michael Micksche,
Hedwig Sutterlüty,
and
Walter Berger*
* Author for correspondence (e-mail: walter.berger{at}meduniwien.ac.at)
The major vault protein (MVP) is the main component of vaults, large ribonucleoprotein particles implicated in the regulation of cellular signaling cascades and multidrug resistance. Here, we identify MVP as an interferon
(IFN-
)-inducible protein. Treatment with IFN-
resulted in a significant upregulation of MVP promoter activity as well as mRNA and protein levels. Activation of MVP expression by IFN-
involved transcriptional upregulation through the JAK/STAT pathway based on an interaction of STAT1 with an interferon-
-activated site (GAS) within the proximal MVP promoter. Mutation of this site distinctly reduced basal as well as IFN-
-stimulated MVP transcription. IFN-
also significantly enhanced the translation rate of MVP. Ectopic MVP overexpression in the MVP-negative lung cancer cell model H65 led to a downregulation of three known IFN-
-regulated genes, namely ICAM-1, CD13 and CD36. Additionally, presence of MVP in H65 cells blocked both basal and IFN-
-induced ICAM-1 expression whereas downmodulation of endogenous MVP levels by shRNA enhanced IFN-
-induced ICAM-1 expression in U373 glioblastoma cells. MVP-mediated IFN-
insensitivity was accompanied by significantly reduced STAT1 phosphorylation at Y701 and diminished translocation of STAT1 into the nucleus. Summarizing, we identify MVP as an IFN-
-responsive gene interfering with IFN-
-activated JAK/STAT signals. These data further substantiate that the vault particle functions as a general interaction platform for cellular signaling cascades.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Herberger, W. Berger, H. Puhalla, K. Schmid, S. Novak, A. Brandstetter, C. Pirker, T. Gruenberger, and M. Filipits
Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells
Mol. Cancer Ther.,
June 1, 2009;
8(6):
1547 - 1556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tanaka, K. Kato, E. Yamashita, T. Sumizawa, Y. Zhou, M. Yao, K. Iwasaki, M. Yoshimura, and T. Tsukihara
The Structure of Rat Liver Vault at 3.5 Angstrom Resolution
Science,
January 16, 2009;
323(5912):
384 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fischer, N. Taylor, S. Allerstorfer, M. Grusch, G. Sonvilla, K. Holzmann, U. Setinek, L. Elbling, H. Cantonati, B. Grasl-Kraupp, et al.
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition
Mol. Cancer Ther.,
October 1, 2008;
7(10):
3408 - 3419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Haan, C. Margue, A. Engrand, C. Rolvering, H. Schmitz-Van de Leur, P. C. Heinrich, I. Behrmann, and C. Haan
Dual Role of the Jak1 FERM and Kinase Domains in Cytokine Receptor Binding and in Stimulation-Dependent Jak Activation
J. Immunol.,
January 15, 2008;
180(2):
998 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Khodarev, A. J. Minn, E. V. Efimova, T. E. Darga, E. Labay, M. Beckett, H. J. Mauceri, B. Roizman, and R. R. Weichselbaum
Signal Transducer and Activator of Transcription 1 Regulates Both Cytotoxic and Prosurvival Functions in Tumor Cells
Cancer Res.,
October 1, 2007;
67(19):
9214 - 9220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Kowalski, A. Dubouix-Bourandy, M. Bajmoczi, D. E. Golan, T. Zaidi, Y. S. Coutinho-Sledge, M. P. Gygi, S. P. Gygi, E. A. C. Wiemer, and G. B. Pier
Host Resistance to Lung Infection Mediated by Major Vault Protein in Epithelial Cells
Science,
July 6, 2007;
317(5834):
130 - 132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Komori, N. Takemori, H. K. Kim, A. Singh, S.-H. Hwang, R. D. Foreman, K. Chung, J. M. Chung, and H. Matsumoto
Proteomics study of neuropathic and nonneuropathic dorsal root ganglia: altered protein regulation following segmental spinal nerve ligation injury
Physiol Genomics,
April 24, 2007;
29(2):
215 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Suprenant, N. Bloom, J. Fang, and G. Lushington
The major vault protein is related to the toxic anion resistance protein (TelA) family
J. Exp. Biol.,
March 15, 2007;
210(6):
946 - 955.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2006